Article No
BE0150-50MG
InVivoMAb anti-mouse CD19
InVivoMAb anti-mouse CD19
Antibodies Primary
Specifications
| MW | 150 kDa |
| Application | Depletion, FC, Neutralization |
| Article No | BE0150-50MG |
| Country Availability | SE, FI, DK, NO, EE, LV, LT |
| Clone | 1D3 |
| Clone Type | monoclonal |
| Concentration | 4-11 mg/ml |
| Conjugation | Unconjugated |
| Description | InVivoMAb anti-mouse CD19 |
| Supplier | BioXCell |
| Endotoxin | <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay|InVivoMAb |
| Immunogen | K562 cells expressing the extracellular domain of mouse CD19 |
| Isotype | IgG2a k |
| Keywords | In Vivo |
| Alias Names | In Vivo, bulk size |
| Product Type | Antibodies Primary |
| Purity | >95% |
| Shipping Information | BLUE ICE |
| Size | 50 mg |
| Source / Host | rat |
| Species Reactivity | mouse |
| Storage | 4°C |
| Product Page Updated | 2024-03-25T10:15:09.827Z |
